Login / Signup

Molidustat for the treatment of renal anaemia in patients with non-dialysis-dependent chronic kidney disease: design and rationale of two phase III studies.

Hiroyasu YamamotoMegumi TaguchiYoshimi MatsudaKazuma IekushiTakashi YamadaTadao Akizawa
Published in: BMJ open (2019)
NCT03350321; Pre-results, NCT03350347; Pre-results.
Keyphrases
  • chronic kidney disease
  • phase iii
  • end stage renal disease
  • clinical trial
  • open label
  • phase ii
  • double blind
  • placebo controlled
  • randomized controlled trial
  • case control